New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
20:25 EDTJNJ, JNJ, JPM, JPM, GS, GS, CMA, CMA, JBHT, JBHT, CBSH, CBSH, WWW, WWW, WAFD, WAFD, WABC, WABCNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.55; JPMorgan (JPM), consensus $1.29; Goldman Sachs (GS), consensus $3.05; Comerica (CMA), consensus 76c; JB Hunt (JBHT), consensus 79c; Commerce Bancshares (CBSH), consensus 68c; Wolverine World Wide (WWW), consensus 27c; Washington Federal (WAFD), consensus 37c; Westamerica Bancorp. (WABC), consensus 58c.
News For JNJ;JPM;GS;CMA;JBHT;CBSH;WWW;WAFD;WABC From The Last 14 Days
Check below for free stories on JNJ;JPM;GS;CMA;JBHT;CBSH;WWW;WAFD;WABC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 25, 2014
07:32 EDTGSGoldman likely to name small new-partner class for 2014, WSJ reports
Subscribe for More Information
07:03 EDTJNJVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.
August 24, 2014
21:23 EDTGSLender group set to offer EDMC revised debt package, NY Post says
Subscribe for More Information
16:56 EDTGSGoldman likely to limit partner designations this fall, WSJ says
Subscribe for More Information
August 22, 2014
17:18 EDTGSGoldman Sachs announces agreements with FHFA to repurchase $3.15B in RMBS
Subscribe for More Information
13:41 EDTGSGoldman Sachs near $1.1B payment to settle FHFA claims, FT reports
Subscribe for More Information
06:42 EDTGSBlackstone in discussions to back China-based fund, Bloomberg says
Blackstone (BX) is in discussions to possibly back Hong Kong-based distressed fund, Arkkan Capital Management, which was founded by the former global leader of Goldman Sachs' (GS) special situations division Jason Brown, according to Bloomberg, citing two people with knowledge of the matter. Reference Link
August 21, 2014
08:31 EDTJPMMorgan Stanley, JP Morgan selected by Shake Shack to lead IPO, Reuters says
JP Morgan (JPM) and Morgan Stanley (MS) have been picked by Shake Shack to lead the fast-food restaurant chain's IPO, sources tell Reuters. The offering could come as early as this year. Reference Link
06:43 EDTJPM, GSRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
18:29 EDTJPM, GSBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
11:37 EDTGSGoldman ups U.S. junior employees FY15 wages by 20%, Bloomberg says
Subscribe for More Information
10:32 EDTGSGoldman to up U.S. junior employees FY15 salaries by 20%, Bloomberg says
Subscribe for More Information
August 19, 2014
10:13 EDTWWWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:39 EDTWWWWolverine World Wide upgraded at KeyBanc
Subscribe for More Information
06:34 EDTGSGoldman abandons effort to toss out $1B Gaddafi suit, Telegraph says
Goldman Sachs (GS) abandoned its effort to toss out a London court suit from the Libyan Investment Authority who alleged that the bank lost over $1B worth of funds during the final years of Muammar Gaddafi's reign as dictator, according to the Telegraph, citing comments from the LIA. The LIA sued both Goldman and Societe Generale (SCGLY) over claims that the banks' London divisions took-in exorbitant fees while losing money in derivative trades. Reference Link
05:29 EDTWWWWolverine World Wide upgraded to Buy from Hold at KeyBanc
Subscribe for More Information
August 18, 2014
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:32 EDTGSProcter & Gamble likely to divest Duracell, Braun, Reuters reports
Subscribe for More Information
09:20 EDTGSDeutsche Bank appoints Shannon Americas Chief Information Officer
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use